nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA1B—connective tissue—Graves' disease	0.0637	0.167	CbGeAlD
Gabapentin—CACNA1B—pituitary gland—Graves' disease	0.0491	0.129	CbGeAlD
Gabapentin—BCAT1—pituitary gland—Graves' disease	0.0386	0.101	CbGeAlD
Gabapentin—BCAT1—adipose tissue—Graves' disease	0.0384	0.101	CbGeAlD
Gabapentin—CACNA2D2—pituitary gland—Graves' disease	0.0354	0.0927	CbGeAlD
Gabapentin—Ageusia—Methimazole—Graves' disease	0.0347	0.0562	CcSEcCtD
Gabapentin—BCAT1—thyroid gland—Graves' disease	0.0333	0.0871	CbGeAlD
Gabapentin—Skin ulcer—Propylthiouracil—Graves' disease	0.0307	0.0497	CcSEcCtD
Gabapentin—CACNA2D2—thyroid gland—Graves' disease	0.0305	0.0799	CbGeAlD
Gabapentin—Ageusia—Propylthiouracil—Graves' disease	0.0295	0.0478	CcSEcCtD
Gabapentin—CACNA2D1—adipose tissue—Graves' disease	0.0253	0.0664	CbGeAlD
Gabapentin—ADORA1—adipose tissue—Graves' disease	0.0244	0.064	CbGeAlD
Gabapentin—Lymphadenopathy—Methimazole—Graves' disease	0.0239	0.0387	CcSEcCtD
Gabapentin—CACNA2D1—thyroid gland—Graves' disease	0.0219	0.0575	CbGeAlD
Gabapentin—ADORA1—thyroid gland—Graves' disease	0.0212	0.0554	CbGeAlD
Gabapentin—Lymphadenopathy—Propylthiouracil—Graves' disease	0.0204	0.0329	CcSEcCtD
Gabapentin—Hepatic failure—Propylthiouracil—Graves' disease	0.0193	0.0313	CcSEcCtD
Gabapentin—Renal failure acute—Propylthiouracil—Graves' disease	0.0188	0.0304	CcSEcCtD
Gabapentin—Drowsiness—Methimazole—Graves' disease	0.0157	0.0255	CcSEcCtD
Gabapentin—Neuropathy peripheral—Methimazole—Graves' disease	0.0154	0.025	CcSEcCtD
Gabapentin—Jaundice—Methimazole—Graves' disease	0.0153	0.0248	CcSEcCtD
Gabapentin—Hepatitis—Methimazole—Graves' disease	0.0141	0.0229	CcSEcCtD
Gabapentin—Drowsiness—Propylthiouracil—Graves' disease	0.0134	0.0216	CcSEcCtD
Gabapentin—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0131	0.0212	CcSEcCtD
Gabapentin—Jaundice—Propylthiouracil—Graves' disease	0.013	0.0211	CcSEcCtD
Gabapentin—Alopecia—Methimazole—Graves' disease	0.0125	0.0202	CcSEcCtD
Gabapentin—Haemorrhage—Propylthiouracil—Graves' disease	0.012	0.0194	CcSEcCtD
Gabapentin—Hepatitis—Propylthiouracil—Graves' disease	0.012	0.0194	CcSEcCtD
Gabapentin—Vertigo—Methimazole—Graves' disease	0.0111	0.0179	CcSEcCtD
Gabapentin—Leukopenia—Methimazole—Graves' disease	0.011	0.0178	CcSEcCtD
Gabapentin—Alopecia—Propylthiouracil—Graves' disease	0.0106	0.0172	CcSEcCtD
Gabapentin—Arthralgia—Methimazole—Graves' disease	0.0105	0.0169	CcSEcCtD
Gabapentin—Myalgia—Methimazole—Graves' disease	0.0105	0.0169	CcSEcCtD
Gabapentin—Dysgeusia—Propylthiouracil—Graves' disease	0.0102	0.0166	CcSEcCtD
Gabapentin—Oedema—Methimazole—Graves' disease	0.01	0.0162	CcSEcCtD
Gabapentin—Thrombocytopenia—Methimazole—Graves' disease	0.00983	0.0159	CcSEcCtD
Gabapentin—Vertigo—Propylthiouracil—Graves' disease	0.0094	0.0152	CcSEcCtD
Gabapentin—Leukopenia—Propylthiouracil—Graves' disease	0.00936	0.0151	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00915	0.0148	CcSEcCtD
Gabapentin—Paraesthesia—Methimazole—Graves' disease	0.00902	0.0146	CcSEcCtD
Gabapentin—Somnolence—Methimazole—Graves' disease	0.00893	0.0144	CcSEcCtD
Gabapentin—Arthralgia—Propylthiouracil—Graves' disease	0.00891	0.0144	CcSEcCtD
Gabapentin—Myalgia—Propylthiouracil—Graves' disease	0.00891	0.0144	CcSEcCtD
Gabapentin—Dyspepsia—Methimazole—Graves' disease	0.00884	0.0143	CcSEcCtD
Gabapentin—Oedema—Propylthiouracil—Graves' disease	0.00854	0.0138	CcSEcCtD
Gabapentin—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00836	0.0135	CcSEcCtD
Gabapentin—Urticaria—Methimazole—Graves' disease	0.00798	0.0129	CcSEcCtD
Gabapentin—Body temperature increased—Methimazole—Graves' disease	0.00794	0.0128	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00778	0.0126	CcSEcCtD
Gabapentin—Paraesthesia—Propylthiouracil—Graves' disease	0.00767	0.0124	CcSEcCtD
Gabapentin—Somnolence—Propylthiouracil—Graves' disease	0.00759	0.0123	CcSEcCtD
Gabapentin—Dyspepsia—Propylthiouracil—Graves' disease	0.00751	0.0122	CcSEcCtD
Gabapentin—Pruritus—Methimazole—Graves' disease	0.0071	0.0115	CcSEcCtD
Gabapentin—Urticaria—Propylthiouracil—Graves' disease	0.00678	0.011	CcSEcCtD
Gabapentin—Body temperature increased—Propylthiouracil—Graves' disease	0.00675	0.0109	CcSEcCtD
Gabapentin—Vomiting—Methimazole—Graves' disease	0.00638	0.0103	CcSEcCtD
Gabapentin—Rash—Methimazole—Graves' disease	0.00633	0.0102	CcSEcCtD
Gabapentin—Dermatitis—Methimazole—Graves' disease	0.00632	0.0102	CcSEcCtD
Gabapentin—Headache—Methimazole—Graves' disease	0.00629	0.0102	CcSEcCtD
Gabapentin—Pruritus—Propylthiouracil—Graves' disease	0.00604	0.00977	CcSEcCtD
Gabapentin—Nausea—Methimazole—Graves' disease	0.00596	0.00964	CcSEcCtD
Gabapentin—Vomiting—Propylthiouracil—Graves' disease	0.00543	0.00878	CcSEcCtD
Gabapentin—Rash—Propylthiouracil—Graves' disease	0.00538	0.00871	CcSEcCtD
Gabapentin—Dermatitis—Propylthiouracil—Graves' disease	0.00538	0.0087	CcSEcCtD
Gabapentin—Headache—Propylthiouracil—Graves' disease	0.00535	0.00865	CcSEcCtD
Gabapentin—Nausea—Propylthiouracil—Graves' disease	0.00507	0.0082	CcSEcCtD
